Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1960 Nov 26;2(5212):1567–1569. doi: 10.1136/bmj.2.5212.1567

Mode of Action and Side-effects of Phenformin Hydrochloride

Robert S Walker, Adam L Linton, W S T Thomson
PMCID: PMC2098383  PMID: 13782756

Full text

PDF
1567

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. KRALL L. P., BRADLEY R. F. Clinical evaluation of formamidinyliminourea, a new biguanide oral blood sugar lowering compound: comparison with other hypoglycemic agents. Ann Intern Med. 1959 Mar;50(3):586–613. doi: 10.7326/0003-4819-50-3-586. [DOI] [PubMed] [Google Scholar]
  2. KRALL L. P., CAMERINI-DAVALOS R. Early clinical evaluation of a new oral non-sulfonylurea hypoglycemic agent. Proc Soc Exp Biol Med. 1957 Jun;95(2):345–347. doi: 10.3181/00379727-95-23215. [DOI] [PubMed] [Google Scholar]
  3. NIELSEN R. L., SWANSON H. E., TANNER D. C., WILLIAMS R. H., O'CONNELL M. Effects on blood sugar of a new potent hypoglycemic compound. AMA Arch Intern Med. 1958 Feb;101(2):211–215. doi: 10.1001/archinte.1958.00260140043008. [DOI] [PubMed] [Google Scholar]
  4. ODELL W. D., TANNER D. C., STEINER D. F., WILLIAMS R. H. Phenethyl-, amyl-, and isoamylbiguanide in the treatment of diabetes mellitus. AMA Arch Intern Med. 1958 Oct;102(4):520–526. doi: 10.1001/archinte.1958.00260210006002. [DOI] [PubMed] [Google Scholar]
  5. POMERANZE J. A new oral hypoglycemic drug. N Y State J Med. 1958 Dec 1;58(23):3824–3826. [PubMed] [Google Scholar]
  6. POMERANZE J., FUJIY H., MOURATOFF G. T. Clinical report of a new hypoglycemic agent. Proc Soc Exp Biol Med. 1957 May;95(1):193–194. doi: 10.3181/00379727-95-23164. [DOI] [PubMed] [Google Scholar]
  7. TYBERGHEIN J. M., WILLIAMS R. H. Metabolic effects of phenethyldiguanide, a new hypoglycemic compound. Proc Soc Exp Biol Med. 1957 Oct;96(1):29–32. doi: 10.3181/00379727-96-23386. [DOI] [PubMed] [Google Scholar]
  8. WALKER R. S., LINTON A. L. Phenethyldiguanide: a dangerous side-effect. Br Med J. 1959 Nov 14;2(5158):1005–1006. doi: 10.1136/bmj.2.5158.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. WICK A. N., LARSON E. R., SERIF G. S. A site of action of phenethylbiguanide, a hypoglycemic compound. J Biol Chem. 1958 Aug;233(2):296–298. [PubMed] [Google Scholar]
  10. WILLIAMS R. H., TANNER D. C., ODELL W. D. Hypoglycemic actions of phenethylamyl-, and isoamyl-diguanide. Diabetes. 1958 Mar-Apr;7(2):87–92. doi: 10.2337/diab.7.2.87. [DOI] [PubMed] [Google Scholar]
  11. WILLIAMS R. H., TYBERGHEIN J. M., HYDE P. M., NIELSEN R. L. Studies related to the hypoglycemic action of phenethyldiguanide. Metabolism. 1957 Jul;6(4):311–319. [PubMed] [Google Scholar]
  12. WRENSHALL G. A., BEST C. H. Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulfonylureas in the treatment of diabetes in man; a comparison. Can Med Assoc J. 1956 Jun 15;74(12):968–972. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES